Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Cervarix Stories

2008-11-05 00:00:15

The human papillomavirus, HPV, in cervical as well as head and neck cancers makes them resistant to therapy, U.S. researchers said. Researchers at the University of California, Los Angeles, Jonsson Cancer Center, said virtually all human cancers experience a state called intratumoral hypoxia, or a low amount of oxygen within the tumor. Senior author Dr. Matthew Rettig showed that the HPV-positive cancers adapted to and took advantage of the hypoxic environment by expressing a protein that...

2008-10-17 06:00:06

By Generic For most women, it's a choice whether or not they want Gardasil -- a vaccine that protects against the sexually transmitted human papillomavirus (HPV). Not so for immigrant families with young daughters who are applying for U.S. citizenship. The only choice they have is to either abide by the mandate or give up their American Dream. A 12-year-old immigration law boils down vaccine requirements for green-card applicants to an issue of semantics. Accordingly, vaccines merely...

2008-10-10 21:00:02

One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said. The 25.1 percent vaccination rate among 13- to 17-year-olds provides the first national estimate of use of Merck & Co.'s Gardasil vaccine, the Centers for Disease Control and Prevention said. Gardasil, administered in a three-dose series, is a vaccine against certain types of human papillomavirus, which infects the skin and mucous membranes. Human...

2008-10-10 18:00:05

ATLANTA - One in four teen girls have rolled up their sleeves for the relatively new vaccine against cervical cancer, federal health officials said Thursday. The figures represent the government's first substantial study of vaccination rates for the Gardasil vaccine - Merck & Co.'s heavily advertised, three-shot series that targets the sexually transmitted human papillomavirus. The vaccine protects against strains of the virus that cause about 70 percent of cervical cancers. Health...

2008-10-09 09:00:52

ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine technology is exclusively licensed from Cedars-Sinai Medical Center. The patent claims are broad and include compositions of peptides for cancer immunotherapy as well as methods for inducing immune responses against tumor antigens in cancer patients. The vaccine being...

2008-09-25 17:46:47

By JAN DISLEY A CATHOLIC school is set to become the first in the country to ban the new cervical cancer jabs. Governors who have already criticised the jabs for "encouraging sexual promiscuity" now say they won't allow pupils to be vaccinated on school grounds. The new jab will be given nationally to girls aged 12 and 13 to protect them against the sexually transmitted papilloma virus, linked to cervical cancer. Experts believe the three injections of the vaccine Cervarix over six...

2008-09-18 00:00:30

The new vaccination for girls against cervical cancer has been welcomed by Swansea East AM Val Lloyd. In the next few weeks girls aged 12 and 13 will receive their first dose of the new human papillona virus (HPV) vaccine, which protects them from two viruses that cause around 70 per cent of cervical cancers. The Assembly Government said Swansea would lead the national roll-out of the vaccine. Val Lloyd, who urges every girl in year eight to take advantage of the programme, said: "I am...

2008-09-17 16:51:33

SCHOOLGIRLS in Bridgend will start to receive a cervical cancer vaccine next month. The programme against the human papilloma virus will be rolled out to 12 and 13-year-old girls at secondary schools in the borough. The HPV vaccine - which requires three jabs - protects against two strains of the virus which cause the majority of cases of cervical cancer. Abertawe Bro Morgannwg University NHS Trust will provide the new HPV vaccine in schools through the school health nursing service....

2008-09-16 21:00:29

By Mark Branagan Hull Teaching Primary Care Trust is taking part in a national immunisation programme by offering the Human Papilloma Virus (HPV) vaccine to girls aged 12 and 13 through the local school nursing service. The vaccine will be administered to 1,271 Year 8 girls in all secondary schools, independent schools and special educational units across Hull in the first year. A catch-up programme for young women up to the age of 18 will also begin this year through a number of GP...

2008-09-15 06:00:00

By Catherine Vonledebur, HEALTH REPORTER Health chiefs in Coventry are launching a vaccination programme to protect 2,000 girls against the main cervical cancer virus. The Human Papilloma Virus (HPV) programme is being launched in secondary schools city wide this autumn as the new school term starts. All 12 and 13-year-old girls in Year 8 in Coventry are to be vaccinated against HPV, which causes most types of cervical cancer. A two-year catch-up vaccination campaign starting in...